A Trial to Evaluate the Precision and Accuracy of the NBM-200 Series When Used in a Continuous Prospective Mode

UnknownOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

November 30, 2013

Conditions
Anemia
Trial Locations (1)

52621

The Chaim Sheba Medical Center at Tel Hashomer, Ramat Gan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

OrSense, Ltd.

INDUSTRY

NCT01917487 - A Trial to Evaluate the Precision and Accuracy of the NBM-200 Series When Used in a Continuous Prospective Mode | Biotech Hunter | Biotech Hunter